Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 7.42 USD 2.77% Market Closed
Market Cap: 271.1m USD
Have any thoughts about
Iteos Therapeutics Inc?
Write Note

Intrinsic Value

ITOS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ITOS stock under the Base Case scenario is 2.13 USD. Compared to the current market price of 7.42 USD, Iteos Therapeutics Inc is Overvalued by 71%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ITOS Intrinsic Value
2.13 USD
Overvaluation 71%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Iteos Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ITOS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ITOS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ITOS?
Bearish
Neutral
Bullish

Fundamental Analysis

7.42 USD
+2.77%
+2.77%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Iteos Therapeutics Inc
US
Biotechnology
Market Cap
271m USD
IPO
Jul 24, 2020
Employees
94
United States of America
Market Cap
271m USD
Industry
Biotechnology
IPO
Jul 24, 2020
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Iteos Therapeutics Inc

Provide an overview of the primary business activities
of Iteos Therapeutics Inc.

What unique competitive advantages
does Iteos Therapeutics Inc hold over its rivals?

What risks and challenges
does Iteos Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Iteos Therapeutics Inc recently?

Summarize the latest earnings call
of Iteos Therapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Iteos Therapeutics Inc.

Provide P/S
for Iteos Therapeutics Inc.

Provide P/E
for Iteos Therapeutics Inc.

Provide P/OCF
for Iteos Therapeutics Inc.

Provide P/FCFE
for Iteos Therapeutics Inc.

Provide P/B
for Iteos Therapeutics Inc.

Provide EV/S
for Iteos Therapeutics Inc.

Provide EV/GP
for Iteos Therapeutics Inc.

Provide EV/EBITDA
for Iteos Therapeutics Inc.

Provide EV/EBIT
for Iteos Therapeutics Inc.

Provide EV/OCF
for Iteos Therapeutics Inc.

Provide EV/FCFF
for Iteos Therapeutics Inc.

Provide EV/IC
for Iteos Therapeutics Inc.

Show me price targets
for Iteos Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Iteos Therapeutics Inc?

How accurate were the past Revenue estimates
for Iteos Therapeutics Inc?

What are the Net Income projections
for Iteos Therapeutics Inc?

How accurate were the past Net Income estimates
for Iteos Therapeutics Inc?

What are the EPS projections
for Iteos Therapeutics Inc?

How accurate were the past EPS estimates
for Iteos Therapeutics Inc?

What are the EBIT projections
for Iteos Therapeutics Inc?

How accurate were the past EBIT estimates
for Iteos Therapeutics Inc?

Compare the revenue forecasts
for Iteos Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Iteos Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Iteos Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Iteos Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Iteos Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Iteos Therapeutics Inc with its peers.

Analyze the financial leverage
of Iteos Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Iteos Therapeutics Inc.

Provide ROE
for Iteos Therapeutics Inc.

Provide ROA
for Iteos Therapeutics Inc.

Provide ROIC
for Iteos Therapeutics Inc.

Provide ROCE
for Iteos Therapeutics Inc.

Provide Gross Margin
for Iteos Therapeutics Inc.

Provide Operating Margin
for Iteos Therapeutics Inc.

Provide Net Margin
for Iteos Therapeutics Inc.

Provide FCF Margin
for Iteos Therapeutics Inc.

Show all solvency ratios
for Iteos Therapeutics Inc.

Provide D/E Ratio
for Iteos Therapeutics Inc.

Provide D/A Ratio
for Iteos Therapeutics Inc.

Provide Interest Coverage Ratio
for Iteos Therapeutics Inc.

Provide Altman Z-Score Ratio
for Iteos Therapeutics Inc.

Provide Quick Ratio
for Iteos Therapeutics Inc.

Provide Current Ratio
for Iteos Therapeutics Inc.

Provide Cash Ratio
for Iteos Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Iteos Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Iteos Therapeutics Inc?

What is the current Free Cash Flow
of Iteos Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Iteos Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Iteos Therapeutics Inc

Current Assets 544.9m
Cash & Short-Term Investments 488.7m
Receivables 42.8m
Other Current Assets 13.4m
Non-Current Assets 178.2m
Long-Term Investments 160.2m
PP&E 10.9m
Other Non-Current Assets 7.1m
Current Liabilities 36.8m
Accounts Payable 7.2m
Accrued Liabilities 28.2m
Other Current Liabilities 1.4m
Non-Current Liabilities 54.6m
Other Non-Current Liabilities 54.6m
Efficiency

Earnings Waterfall
Iteos Therapeutics Inc

Revenue
35m USD
Operating Expenses
-185.3m USD
Operating Income
-150.3m USD
Other Expenses
29.1m USD
Net Income
-121.3m USD

Free Cash Flow Analysis
Iteos Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ITOS Profitability Score
Profitability Due Diligence

Iteos Therapeutics Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
30/100
Profitability
Score

Iteos Therapeutics Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

ITOS Solvency Score
Solvency Due Diligence

Iteos Therapeutics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
68/100
Solvency
Score

Iteos Therapeutics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ITOS Price Targets Summary
Iteos Therapeutics Inc

Wall Street analysts forecast ITOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITOS is 25.5 USD with a low forecast of 16.16 USD and a high forecast of 49.35 USD.

Lowest
Price Target
16.16 USD
118% Upside
Average
Price Target
25.5 USD
244% Upside
Highest
Price Target
49.35 USD
565% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ITOS?

Click here to dive deeper.

Dividends

Iteos Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ITOS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ITOS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ITOS News

See Also

Discover More
What is the Intrinsic Value of one ITOS stock?

The intrinsic value of one ITOS stock under the Base Case scenario is 2.13 USD.

Is ITOS stock undervalued or overvalued?

Compared to the current market price of 7.42 USD, Iteos Therapeutics Inc is Overvalued by 71%.

Back to Top